Among these cell lines, A549 (lung carcinoma), MCF7 (mammary adenocarcinoma) and T47D (mammary ductal carcinoma) were selected for low NLRC5 expression and varying levels of HLA expression (Supplementary Figure S2B). Here, NLRC5 is linked to lung carcinoma.